Co-Authors
This is a "connection" page, showing publications co-authored by Zhi-Gang She and Xiao-Jing Zhang.
Connection Strength
1.355
-
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metab. 2020 08 04; 32(2):176-187.e4.
Score: 0.222
-
Time to step-up the fight against NAFLD. Hepatology. 2018 06; 67(6):2068-2071.
Score: 0.191
-
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients. Curr Med Res Opin. 2021 06; 37(6):917-927.
Score: 0.059
-
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med (N Y). 2021 Apr 09; 2(4):435-447.e4.
Score: 0.058
-
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. Cell Metab. 2021 02 02; 33(2):258-269.e3.
Score: 0.058
-
No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19. World J Clin Cases. 2020 Nov 26; 8(22):5576-5588.
Score: 0.057
-
Kidney Function Indicators Predict Adverse Outcomes of COVID-19. Med (N Y). 2021 Jan 15; 2(1):38-48.e2.
Score: 0.057
-
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 10 06; 32(4):537-547.e3.
Score: 0.056
-
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020 08; 72(2):389-398.
Score: 0.056
-
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. Hypertension. 2020 10; 76(4):1104-1112.
Score: 0.056
-
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 08; 76(2):e15-e17.
Score: 0.055
-
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 06 02; 31(6):1068-1077.e3.
Score: 0.055
-
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020 06 05; 126(12):1671-1681.
Score: 0.055
-
Wang et al. reply. Nat Med. 2018 06; 24(6):700-701.
Score: 0.048
-
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat Med. 2018 02; 24(2):213-223.
Score: 0.047
-
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat Med. 2018 01; 24(1):84-94.
Score: 0.047
-
Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med. 2017 10 06; 23(10):1241.
Score: 0.046
-
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4. Nat Med. 2017 Jun; 23(6):742-752.
Score: 0.045
-
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. Nat Med. 2017 Apr; 23(4):439-449.
Score: 0.044
-
Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice. J Am Heart Assoc. 2017 02 20; 6(2).
Score: 0.044